The clinical features of XIAP deficiency are characterized by susceptibility to Epstein–Barr virus (EBV) infection, recurrent HLH with/without EBV, splenomegaly, inflammatory bowel disease (IBD), and hypogammaglobulinemia. Here, XIAP is linked to inflammatory bowel disease.